dipyridamole has been researched along with Infection in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fong, JS | 1 |
de Chadarevian, JP | 1 |
Kaplan, BS | 1 |
Pinna, AD | 1 |
Argiolu, F | 1 |
Marongiu, L | 1 |
Pinna, DC | 1 |
Dacie, JV | 1 |
1 review available for dipyridamole and Infection
Article | Year |
---|---|
Hemolytic-uremic syndrome. Current concepts and management.
Topics: Anemia, Hemolytic; Blood Transfusion; Child; Child, Preschool; Dipyridamole; Epoprostenol; Follow-Up | 1982 |
2 other studies available for dipyridamole and Infection
Article | Year |
---|---|
Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
Topics: Aspirin; Blood Transfusion; Cerebrovascular Disorders; Child; Dipyridamole; Female; Follow-Up Studie | 1988 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; | 1973 |